Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AC Immune (ACIU) Assets Average: 2016-2025

Historic Assets Average for AC Immune (ACIU) over the last 9 years, with Sep 2025 value amounting to $107.4 million.

  • AC Immune's Assets Average fell 60.57% to $107.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $107.4 million, marking a year-over-year decrease of 60.57%. This contributed to the annual value of $239.1 million for FY2025, which is N/A change from last year.
  • As of Q3 2025, AC Immune's Assets Average stood at $107.4 million, which was down 8.62% from $117.5 million recorded in Q2 2025.
  • Over the past 5 years, AC Immune's Assets Average peaked at $241.8 billion during Q2 2021, and registered a low of $107.4 million during Q3 2025.
  • Its 3-year average for Assets Average is $172.7 million, with a median of $178.3 million in 2023.
  • As far as peak fluctuations go, AC Immune's Assets Average surged by 83,057.76% in 2021, and later tumbled by 99.90% in 2022.
  • Quarterly analysis of 5 years shows AC Immune's Assets Average stood at $110.9 billion in 2021, then crashed by 99.82% to $202.9 million in 2022, then dropped by 9.33% to $184.0 million in 2023, then decreased by 23.32% to $141.1 million in 2024, then plummeted by 60.57% to $107.4 million in 2025.
  • Its last three reported values are $107.4 million in Q3 2025, $117.5 million for Q2 2025, and $117.5 million during Q1 2025.